Abstract
In the last 4 years we have established five long-term cultures from tumor material of Hodgkin’s disease. The in vitro cells have malignant characteristics and represent the in vivo Hodgkin- and Sternberg-Reed-cells as shown by the identity of multiple properties.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borum K (1980) Increasing frequency of acute myeloid leukemia complicating Hodgkin’s disease: A review. Cancer 46: 1247–1252
Coltman CA, Dixon DO (1982) Second malignancies complicating Hodgkin’s disease: A southwest oncology group 10-year follow up. Cancer Treat Rep 66: 1023–1034
De Vita VT, Lewis BJ, Rosenzweig M et al. (1978) The chemotherapy of Hodgkin’s disease. Cancer 42: 979–990
Diehl V, Johannson B (1977) Establishment of peripheral lymphoid cell cultures from patients with Hodgkin’s disease (HD) depending on Epstein-Barr virus (EBV) reactivity and cellular immunity. Blut 34:227–236
Diehl V, Kirchner HH, Schaadt M et al. (1981) Hodgkin’s disease: Establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol 101: 111–124
Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heinz F, Sueno K (1982) Characteristics of Hodgkin’s disease-derived cell lines. Cancer Treat Rep 66:615–632
Fisher RI, Bostick-Bruton F, Diehl V (to be published) Neoplastic cells obtained from Hodgkin’s disease function as accessory cells for mitogen-induced, human T-cell proliferative responses
Fisher RI, Bostick-Bruton F, Sander DN, Diehl V (to be published) Neoplastic cells obtained from Hodgkin’s disease are potent stimulators of human primary mixed lymphocytic cultures
Glicksman HS, Pajak TF, Gottlieb A et al. (1982) Second malignant neoplasms in patients successfully treated for Hodgin’s disease: A cancer and leukemia group B study. Cancer Treat Rep 66: 1035–1044
Kaplan HS (1981) Hodgkin’s disease: Biology, treatment, prognosis. Blood 57: 813
Longo DL, Young RC, De Vita VT (1982) The chemotherapy for Hodgkin’s disease: The remaining challenges. Cancer Treat Rep 66:925–936
Schaadt M, Diehl V, Stein H et al. (1980) Two neoplastic cell-lines with unique features derived from Hodgkin’s disease. Int J Cancer 26: 723–731
Schwab U, Stein H, Gerdes J, Lemke H, Kirchner HH, Schaadt M, Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin’s disease and a subset of normal lymphoid cells. Nature 299: 65
Stein H, Gerdes J, Kirchner HH et al. (1981) Hodgkin’s disease. Immunohistological analysis of Hodgkin- and Sternberg-Reed cells. J Cancer Res Clin Oncol 101: 125–134
Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl V (1982) Identification of Hodgkin- and Sternberg-Reed cells as a unique cell type derived from a newly detected cell population. Int J Cancer 30:445–459
Valagussa P, Santaro A, Kenda R et al. (1980) Second malignancies in Hodgkin’s disease: A complication of certain forms of treatment. Br Med J 280:216–219
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Diehl, V. et al. (1983). Hodgkin’s Disease Cell Lines: Characteristics and Biological Activities. In: Neth, R., Gallo, R.C., Greaves, M.F., Moore, M.A.S., Winkler, K. (eds) Modern Trends in Human Leukemia V. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68761-7_81
Download citation
DOI: https://doi.org/10.1007/978-3-642-68761-7_81
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11858-9
Online ISBN: 978-3-642-68761-7
eBook Packages: Springer Book Archive